The Effect of Self Stigma Tailored Cognitive Behavioral Therapy on Gambling Disorder
1 other identifier
interventional
26
1 country
1
Brief Summary
The goal of this clinical trial was to evaluate whether a cognitive behavioral therapy (CBT) program focused on self-stigma could help reduce both self-stigma and gambling disorder severity in adults diagnosed with gambling disorder. The main questions it aimed to answer were: Did self-stigma-focused CBT lower self-stigmatizing thoughts in individuals with gambling disorder? Did the severity of gambling disorder symptoms decrease after the intervention? Did these changes remain stable after the treatment ended? Did self-stigma play a role in how the treatment worked? Participants were assigned to either an intervention group or a control group. Completed assessments before the treatment, after the treatment, and during the 1 month follow-up period. Participants in the intervention group: Received four sessions of cognitive behavioral therapy (face-to-face or online) targeting self-stigmatizing thoughts related to gambling Researchers compared the intervention and control groups to observe whether self-stigmatization affected treatment outcomes. Surveys used in this study included a self-stigma scale and the South Oaks Gambling Screen (SOGS). A total of 26 participants (13 in each group) were enrolled in the study; in addition, 3 extra participants per group were included to account for possible dropouts. The results were analyzed using statistical methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
April 17, 2025
CompletedFirst Posted
Study publicly available on registry
April 25, 2025
CompletedResults Posted
Study results publicly available
February 5, 2026
CompletedFebruary 5, 2026
January 1, 2026
6 months
April 17, 2025
December 3, 2025
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Self-Stigmatization Score as Measured by the Self-Stigma Scale (SSS). Baseline (Week 0) to Post-treatment (Week 4) and Follow-up (Week 8)
Self-stigma will be measured using the Self-Stigma Scale (SSS). Scores range from 36 to 144, with 72 and higher scores indicating severe self-stigmatization. Changes from baseline (Week0) to post-treatment (Week 4) and follow-up (Week 8) will be analyzed.
post-treatment (Week 4) and follow-up (Week 8)
Change in Gambling Severity Score as Measured by the South Oaks Gambling Screen (SOGS). Baseline (Week 0) to Post-treatment (Week 4) and Follow-up (Week 8)
Gambling severity will be assessed using the South Oaks Gambling Screen (SOGS). Scores range from 0 to 19, with higher scores indicating greater gambling-related problems. Changes from baseline to post-treatment and follow-up will be analyzed.
post-treatment (Week 4) and follow-up (Week 8)
Study Arms (2)
Experimental (Intervention) Group
EXPERIMENTALParticipants in the research arm received "Self Stigma Tailored Cognitive Behavioral Therapy on Gambling Disorder" addition to the standard treatment for Gambling Disorder (GD) provided at the Addiction Clinic. The standard treatment includes the medical treatment for GD and motivational interviews administered by a psychiatrist at the Addiction Clinic where the research is conducted.
Control Group
ACTIVE COMPARATORParticipants in the control group received the standard treatment for Gambling Disorder (GD), as described in the previous paragraph, at the Institute's Addiction Clinic. The duration and type of treatment were tailored to the individual patient by the psychiatrist. During the period when the experimental group received the Self Stigma Tailored Cognitive Behavioral Therapy for Gambling Disorder, the control group participants were placed on the waiting list and did not receive any specific intervention for self-stigma perception.
Interventions
The Self Stigma Tailored Cognitive Behavioral Therapy for Gambling Disorder (SSCBT) is a novel intervention designed specifically for this study and has not been previously used or named in existing literature. This 4-session protocol can be integrated into any part of GD treatment. Each session was accompanied by materials specifically designed for that session's content, and assignments related to the session's topics were given at the end of each session. Session 1: Gambling Disorder from a bio-psycho-social perspective, stigma and self-stigma, CBT introduction, cognitive-behavioral model of self-stigmatization, impact of emotions and cognitive distortions. S. 2: Self-stigmatizing thoughts and behaviors, identifying automatic thoughts with cognitive techniques, cognitive awareness, and restructuring with evidence examination. S. 3: Aligning behaviors with values, cognitive restructuring, behavior change, and self-awareness. S. 4: Prevention strategies, relapse prevention planning.
All participants continued to receive standard pharmacotherapy from their respective psychiatrists.
All participants continued to receive the standard motivational interviewing intervention for addiction from their psychiatrist.
Eligibility Criteria
You may qualify if:
- Meeting the diagnostic criteria for Gambling Disorder (GD) according to the DSM-5:
- Currently receiving or having completed the standard treatment provided at the outpatient clinic.
- Scoring 72 or above on the Self Stigma Scale.
- Being between 18 and 65 years old.
You may not qualify if:
- "Intellectual Disability" classified under neurodevelopmental disorders.
- "Communication Disorders" resulting from neurodevelopmental disorders or another medical condition.
- Based on clinical interviews and DSM-5 diagnostic criteria:
- "Bipolar and Related Disorders" with psychotic features.
- "Depressive Disorders" with psychotic features.
- "Dissociative Disorders" such as depersonalization, derealization, or identity disruption.
- Any disorder classified under "Schizophrenia Spectrum and Other Psychotic Disorders," including schizophrenia, schizotypal personality disorder, and schizoaffective disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University
Izmir, Bornova, 3100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The groups were not fully balanced in baseline gambling severity, which may influence interpretation of the results. The study was not placebo-controlled or blinded, which could affect participant responses. Additionally, the one-month follow-up limits conclusions about the long-term effects of the intervention.Since SSCBT is a newly developed intervention model, further studies with larger and more diverse samples are needed to strengthen the evidence base.
Results Point of Contact
- Title
- Ayça Çınaroğlu Asar
- Organization
- Ege University
Study Officials
- STUDY DIRECTOR
Umut Kırlı, Assoc. Prof.
Ege University, Addiction Clinic within the Institute of Addiction, Toxicology, and Pharmaceutical Sciences.
- PRINCIPAL INVESTIGATOR
Ayça Çınaroğlu Asar, B.A.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 17, 2025
First Posted
April 25, 2025
Study Start
April 1, 2024
Primary Completion
September 30, 2024
Study Completion
November 30, 2024
Last Updated
February 5, 2026
Results First Posted
February 5, 2026
Record last verified: 2026-01